AI medical scribes
30 – 26Commure Scribe by 4
| Dimension | Commure Scribe | DeepScribe | Gap |
|---|---|---|---|
| Access & pricePublished pricing, free tier, credential and regional eligibility, language coverage, and whether one clinician can evaluate the product without entering a sales process. | 8 | 3 | +5 |
| Workflow & templatesTemplate depth and per-clinician customization, breadth of note types and specialties, non-physician coverage, and whether the tool can work on a note it did not draft. | 8 | 5 | +3 |
| Documentation integrityICD-10 specificity, MEAT support, HCC recapture, E/M leveling and denial-risk checks — and whether each suggestion traces to verbatim text in the note so it survives an audit. | 5 | 7 | -2 |
| Clinical reasoningWhether the product reasons about the encounter or only records it: ranked differential, problem-based assessment and plan, red-flag detection, and whether that reasoning is auditable rather than opaque. | 3 | 4 | -1 |
| EHR & deploymentIntegration depth — native embed, authenticated API write-back, browser extension or copy-paste — plus enterprise rollout support and the procurement path. | 6 | 7 | -1 |
Commure Scribe
- Best for
- Allied-health and behavioural-health practices, where WebPT and TherapyNotes both have turn-key integrations, wanting a deeply configurable per-section template system. It is the only scribe scored here that ingests and restructures a note it did not draft.
- Limitation
- One-click EHR sync is Enterprise-gated, so self-serve buyers at this price hand off by copy-paste. E/M, LOS and HCC coding are enterprise-only, and Commure concedes on its own comparison page that its Citations traceability feature is publicly undocumented except for an article explaining how to switch it off.
- Price
- Published: $89/month, or $708/year — a $59/month equivalent
DeepScribe
- Best for
- Community oncology practices on OncoEMR or iKnowMed, where the documentation problem is capturing MEAT criteria against HCC conditions. It is the only tool scored here that documents a per-condition Monitor, Evaluate, Assess and Treat summary.
- Limitation
- Almost nothing is publicly checkable: no price, no template, note-type or specialty count, no developer API and no product documentation site at all. Its widely-quoted 98.8 KLAS score is an Emerging Company Spotlight carrying the vendor's own limited-data asterisk, and the same vendor quotes it as 98.3 elsewhere.
- Price
- Not published; enterprise, sales-led
